We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life News Abiogen Pharma Completes the Acquisition of Effrx See all news Our Products The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis. See all products Partnering with us Our strategy relies on partnerships for shared commercial success. Get in touch
